In the Original Investigation, “Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic,” published online November 8, 2021, and in the January 2022 issue of JAMA Internal Medicine, there were errors and omissions that required correction and clarification. Participants with undefined responses for income and educational level were excluded from the multivariable analysis, leading to minimal changes in the odds ratios in the Abstract, in Table 3, and in eTables 6 and 7 in Supplement 1. In addition, it is now stated that only participants with complete data for model 3 were included in models 1 and 2. Descriptive and missing data regarding depressive symptoms and the numbers of event and numbers of participants for each symptom (accounting for 1%-2% of missing data for each symptom) have been added to the Tables and eTables. eTable 5 in Supplement 1 now includes only participants with complete data for serology results and acknowledges that some participants gave more than 1 response. In eTable 4 in Supplement 1, the Belief+/Serology− and the Belief+/Serology+ columns were reversed. Finally, lack of information on false positives and false negatives has been added as a limitation, and the sentence regarding estimate of the prevalence of past SARS-CoV-2 infection in the population study has been removed from the Discussion. This article has been corrected.
Reference
- 1.Matta J, Wiernik E, Robineau O, et al. ; Santé, Pratiques, Relations et Inégalités Sociales en Population Générale Pendant la Crise COVID-19–Sérologie (SAPRIS-SERO) Study Group . Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182(1):19-25. doi: 10.1001/jamainternmed.2021.6454 [DOI] [PMC free article] [PubMed] [Google Scholar]